---

Cancer Types

Types of Cancer > Gastrointestinal Cancers > Colorectal Cancer > Treatment Options

Treatment Options

Another coup for targeted therapy

Colon Cancer Clinical Research Progress

Eloxatin approved for first line treatment of advanced colorectal cancer

A new monoclonal antibody is approved for the treatment of advanced colon cancer

OncoLink Meet the Professor: Weijing Sun, MD discusses developments in colon cancer therapy

Understanding Your Pathology Report: Colon Cancer

Chemotherapy

A randomized, double-blind, placebo controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222584 or placebo (CONFIRM-1).

CEA and the Oncoscint Scan

CEA as a screening tool

CEA Level

CEA Levels and Colon Cancer

Chemotherapy and Follow Up After B2 Colon Cancer

Chemotherapy for Mucinous Adenocarcinoma of the Colon

Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases

Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases

Hepatic Infusion Increases Survival and Reduces Liver Metastases from Colorectal Cancer when Combined with Chemotherapy

Incorporating Angiogenesis Inhibition with Bevacizumab (anti-VEGF) into Frontline Chemotherapy with Irinotecan (CPT-11), Fluorouracil and Leucovorin (FU/LV) for Advanced Colorectal Cancer (advCRC): A Toxicity Analysis of ECOG Study E2200

Increase in CEA After Colon Surgery

Induction of Protective Host Immunity to Carcinoembryonic Antigen (CEA), a Self-Antigen in CEA Transgenic Mice, by Immunizing with a Recombinant Vaccinia-CEA Virus

Recombinant Human Keratinocyte Growth Factor (RHUKGF) Prevents Chemotherapy-Induced Mucositis In Patients With Advanced Colorectal Cancer: A Randomized Phase II Trial

Rising CEA after colon cancer treatment

Rising CEA after stage II colorectal cancer

Rising CEA after Surgery

Six-Month Chemotherapy Regimen for Colon Cancer Replaces Conventional 12-Month Regimen

The Role of Chemotherapy and Biologic Therapy in the Treatment of Metastatic Colorectal Cancer

Tumor microsatellite instability (MSI) and the benefit of 5-FU based chemotherapy in stage II & stage III colon cancer: a pooled molecular reanalysis of randomized chemotherapy trials

What are the Side Effects of Chemotherapy for Colon Cancer?

Why do I need chemotherapy after my bowel resection?

Current Clinical Trials for Colorectal Cancer at
The University of Pennsylvania

A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL888 in Subjects With Solid Tumors

A Phase 1/2 Study of the Combination of RDEA119 and Sorafenib in Patients With Advanced Cancer

A Phase I Study of Hydroxychloroquine in Combination With Temozolomide in Patients With Advanced Solid Tumors

A Phase I Trial of Hydroxychloroquine in Combination With Temsirolimus in Patients With Refractory Solid Tumors

A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer

A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers

A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer

A Study of V934/V935 in Cancer Patients With Selected Solid Tumors (Merck)

An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor GSK1120212 in Subjects With Solid Tumors or Lymphoma

High Dose Granulocyte Transfusions for the Treatment of Infection in Neutropenia: The RING Study (Resolving Infection in Neutropenia With Granulocytes)

Phase I, Combining Oral Topotecan With Oral Pazopanib

Phase II Randomized Study of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Advanced or Metastatic Colorectal Cancer Treated With Combination Chemotherapy Comprising Oxaliplatin, Fluorouracil, and Leucovorin Calcium (FOLFOX) and Bevacizumab at 5 mg/kg Versus 10 mg/kg or FOLFOX Alone

Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients With One to Three Cerebral Metastases

Colorectal Cancer

Radiation Oncology

Intensity Modulated Radiation Therapy (IMRT) May Reduce Small Bowel, Rectum, and Bladder Complications in Patients with Cervical Cancer Treated to the Pelvis and Paraaortic Area

Is impotence a side effect of radiation for colorectal cancer?

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17

Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17

Postoperative Irradiation for Stage T4 Colon Cancer

Radiation after colon surgery

Side effects of radiation to the colon

The protection of the small intestine and colon from carbon ion particle irradiation by means of Gore-Tex soft tissue patches for patients with pelvic tumors

Urinary and Bowel Incontinence after Radiation

Surgical Oncology

Diet after Bowel Surgery

Gas After Bowel Surgery

Increase in CEA After Colon Surgery

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17

Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17

Outcomes Among African-Americans and Caucasians in Colon Cancer Adjuvant therapy Trials: Findings From the National Surgical Adjuvant Breast and Bowel Project

Questions about an Upcoming Colon Surgery

Radiation after colon surgery

Rising CEA after Surgery

Symptoms After Colon Cancer Surgery

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial

Why do I need chemotherapy after my bowel resection?